NCD Risk Factor Collaboration (NCD-RisC), Rubinstein A. Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024;404(10467):2077-93.
NCD Risk Factor Collaboration (NCD-RisC), Rubinstein A. General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7·5 million participants. Lancet. 2024;404(10455):851-63.
Kruk ME, Sabwa S, Lewis TP, Aniebo I, Arsenault C, Carai S, et al. Population assessment of health system performance in 16 countries. Bull World Health Organ. 2024;102(7):486-97b.
Population assessment of health system performance in 16 countries Ver más »
Kruk ME, Kapoor NR, Lewis TP, Arsenault C, Boutsikari EC, Breda J, et al. Population confidence in the health system in 15 countries: results from the first round of the People's Voice Survey. Lancet Glob Health. 2024;12(1):e100-e11.
Jameleddine M, Harzallah N, Grati H, Odabachian Jebali MC, Chemli J, García Martí S, et al. INEAS's Cost-Effectiveness Analysis of Vemurafenib: Paving the Way for Value-Based Pricing in Tunisia. J Mark Access Health Policy. 2024;12(4):294-305.
Gulayin P, Gutierrez L, Pinto D, Fontana S, Ávila M, Gómez W, et al. A Multi-Component Intervention to Improve Therapeutic Adherence in Uncontrolled Hypertensive Patients Within the Primary Care Level: A Before-and-After Study. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension. 2024;31.
Greeshma J, Mini GK, Marthanda Pillai A, Irazola V. Cardiovascular disease risk factor prevalence among police officials: findings from a cross-sectional study in Kerala, India. J Occup Health. 2024;66(1).
Garcia PJ, Saavedra J, Espinoza-Pajuelo L, Garcia-Terron FA, Garzon X, Rubinstein A, et al. Why Latin America needs a regional Centre for Disease Control and Prevention. Lancet. 2024;403(10446):2763-5.
Why Latin America needs a regional Centre for Disease Control and Prevention Ver más »
Espinola N, Secco A, Balan D, Kanevsky D, Calvi G, Morisset P, et al. Budget impact of upadacitinib in patients with moderate to severe rheumatoid arthritis in Argentina. Rev Peru Med Exp Salud Publica. 2024;41(2):129-39.
Espinola N, Rodríguez Cairoli F, Rojas-Roque C, Luna PC, Kanevsky D, Migliazza V, et al. Budget impact and cost per responder analysis of upadacitinib for the treatment of moderate to severe atopic dermatitis from the perspective of the social security and the private sector in Argentina. Expert Rev Pharmacoecon Outcomes Res. 2024;25(1):101-11.
